SC 13G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No.     )*

 

 

Replimune Group, Inc.

 

(Name of Issuer)

Common Stock, par value $0.001

 

(Title of Class of Securities)

76029N106

 

(CUSIP Number)

                    20 JULY 2018                    

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

 

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


        CUSIP No. 76029N106           13G   Page 2 of 6 Pages

 

  1.  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Forbion Capital Fund III Coöperatief U.A.

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐        (b)  ☐

 

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

The Netherlands

NUMBER OF   SHARES   BENEFICIALLY   OWNED BY   EACH   REPORTING   PERSON  

WITH  

   5.       

SOLE VOTING POWER

 

0

   6.   

SHARED VOTING POWER

 

4,970,121

   7.   

SOLE DISPOSITIVE POWER

 

0

   8.   

SHARED DISPOSITIVE POWER

 

4,970,121

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

4,970,121

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ☐

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

15.75% (1)

12.  

TYPE OF REPORTING PERSON

 

OO

 

 

1

As reported by the Issuer in its 10-Q filed with the Securities and Exchange Commission on November 14, 2018, the total number of shares of Common Stock outstanding was 31,553,672 as of November 12, 2018.


        CUSIP No. 76029N106           13G   Page 3 of 6 Pages

 

  1.  

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)

 

Forbion III Management B.V.

  2.  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  ☐        (b)  ☐

 

  3.  

SEC USE ONLY

 

  4.  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

The Netherlands

NUMBER OF   SHARES   BENEFICIALLY   OWNED BY   EACH   REPORTING   PERSON  

WITH  

   5.       

SOLE VOTING POWER

 

0

   6.   

SHARED VOTING POWER

 

4,970,121

   7.   

SOLE DISPOSITIVE POWER

 

0

   8.   

SHARED DISPOSITIVE POWER

 

4,970,121

  9.  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

4,970,121

10.  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ☐

 

11.  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

15.75% (2)

12.  

TYPE OF REPORTING PERSON

 

OO

 

 

2

As reported by the Issuer in its 10-Q filed with the Securities and Exchange Commission on November 14, 2018, the total number of shares of Common Stock outstanding was 31,553,672 as of November 12, 2018.


        CUSIP No. 76029N106           13G   Page 4 of 6 Pages

 

Item 1(a).

Name of Issuer:

Replimune Group, Inc.

 

Item 1(b).

Address of Issuer’s Principal Executive Offices:

18 Commerce Way, Woburn, MA 01801

 

Item 2(a).

Name of Person Filing:

This Statement is being filed by Forbion Capital Fund III Coöperatief U.A. (“Forbion III COOP”), and Forbion III Management B.V. (“Forbion III”), the director of Forbion III COOP. Forbion III COOP and Forbion III are sometimes referred to collectively herein as the “Reporting Persons”.

 

Item 2(b).

Address of Principal Business Office or, if None, Residence:

The address of the principal business and principal office of each of the Reporting Persons is c/o Forbion Capital Partners, Gooimeer 2-35, 1411 DC Naarden, The Netherlands.

 

Item 2(c).

Citizenship:

Forbion Capital Fund III Coöperatief U.A. – The Netherlands

Forbion III Management B.V. – The Netherlands

 

Item 2(d).

Title of Class of Securities:

Common Stock, par value $0.001 per share

 

Item 2(e).

CUSIP Number:

76029N106

 

Item 3.

 

Item 4.

Ownership.

The following information with respect to the ownership of the Common Stock of the Issuer by the persons filing this Statement is provided as of February 14, 2019:

 

  (a)

Amount beneficially owned: 4,970,121

 

  (b)

Percent of class: 15.75%

 

  (c)

Number of shares as to which such person has:

 

  (i)

Sole power to vote or to direct the vote: 0

 

  (ii)

Shared power to vote or to direct the vote: 4,970,121


        CUSIP No. 76029N106           13G   Page 5 of 6 Pages

 

  (iii)

Sole power to dispose or to direct the disposition of: 0

 

  (iv)

Shared power to dispose or to direct the disposition of: 4,970,121

 

Item 5.

Ownership of Five Percent or Less of a Class.

Not applicable.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group.

The Reporting Persons are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Reporting Persons disclaim membership in a group and this report shall not be deemed an admission by any of the Reporting Persons that they are or may be members of a “group” for purposes of Rule 13d-5 or for any other purpose.

 

Item 9.

Notice of Dissolution of Group.

Not applicable.

 

Item 10.

Certification.

Not applicable .


        CUSIP No. 76029N106           13G   Page 6 of 6 Pages

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 14, 2019

 

FORBION CAPITAL FUND III COÖPERATIEF U.A.
    By:   /s/ M.A. van Osch                       /s/ H.A. Slootweg
          Name: M.A. van Osch             H.A. Slootweg
          Title: its Directors

 

FORBION III MANAGEMENT B.V.
    By:   /s/ M.A. van Osch                       /s/ H.A. Slootweg
          Name: M.A. van Osch             H.A. Slootweg
          Title: its Directors